The therapeutic application of STING agonists in various malignancies has been limited by
factors such as the inability of systemic administration and the immunosuppressive tumor …

Carbon monoxide (CO) gas therapy demonstrates great potential to induce cancer cell
apoptosis and antitumor immune responses, which exhibits tremendous potential in cancer …

Many studies have focused on developing effective therapeutic strategies to selectively
destroy primary tumors, eliminate metastatic lesions, and prevent tumor recurrence with …

Glioblastoma (GBM) is the most malignant brain tumor with unmet therapeutic demand. The
blood‐brain‐barrier (BBB) and tumor heterogeneity limit the treatment effectiveness of …

Development of a nanoscale drug delivery system that can simultaneously exert efficient
tumor therapeutic efficacy while creating the desired antitumor immune responses is still …

Metastasis is one of the main causes of failure in the treatment of triple-negative breast
cancer (TNBC). Immunotherapy brings hope and opportunity to solve this challenge, while …

Minimalist multifunctional platforms for delivering diagnostic and therapeutic agents
effectively and safely into tumor sites are highly desired in nanomedicine. Herein, we …

The intelligent responsive drug delivery system has great application potential in cancer
precision therapy. Although many antitumor methods have been developed based on drug …

Improvement of antitumor effects relies on the development of biocompatible nanomaterials
and combination of various therapies to produce synergistic effects and avoid resistance. In …

Mesoporous silica nanoshell (MSN) coating has been demonstrated as a versatile surface
modification strategy for various kinds of inorganic functional nanoparticles, such as gold …